These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24166212)

  • 1. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
    Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
    Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome].
    Yang Y; Qi X; Ding M; Wang W; Guo H; Gao L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct; 56(5):845-852. PubMed ID: 39397464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
    Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
    Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
    Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
    Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
    Hernández-Molina G; Bermúdez-Bermejo P
    Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
    Luo J; Xu S; Lv Y; Huang X; Zhang H; Zhu X; Wang X
    Int J Rheum Dis; 2019 Feb; 22(2):182-190. PubMed ID: 30411528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.